Shopping Cart
- Remove All
 
Your shopping cart is currently empty
CMLD012612 is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor. It inhibits cell translation and is cytotoxic to NIH/3T3 cells (IC50: 2 nM).

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 
| Description | CMLD012612 is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor. It inhibits cell translation and is cytotoxic to NIH/3T3 cells (IC50: 2 nM).  | 
| In vitro | The primary action of CMLD012612 hinges on its interaction with eIF4A1, as demonstrated by eIF4A1em1jp cells exhibiting at least a 10-fold increased resistance compared to the original NIH/3T3 cells. This resistance is diminished at higher concentrations of CMLD012612, possibly because of the presence of wild-type eIF4A2 in the eIF4A1em1jp cells.  | 
| In vivo | When administered to mice bearing myr-Akt/Em-Myc lymphomas, CMLD012612 (0.2 mg/kg; i.p.; daily; for 5 days; female C57BL/6 mice) treatment effectively synergizes with Doxorubicin, leading to complete tumor loss. CMLD012612 (0.5 mg/kg; i.p.; for 3 hours; female C57BL/6 mice) treatment effectively suppresses liver polysomes 3 hours after injection.  | 
| Molecular Weight | 559.61 | 
| Formula | C31H33N3O7 | 
| Cas No. | 2368900-35-8 | 
| Relative Density. | 1.33 g/cm3 (Predicted) | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.